Published in Blood Weekly, July 20th, 2006
Study 1: Myeloma and lymphoma patients tolerated simvastatin, given immediately prior to chemotherapy, up to a dose of 15 mg/kg/day.
According to recent research published in the Haematologica - the Hematology Journal, "In vitro statins induce apoptosis in myeloma and lymphoma cells in a dose- and time-dependent way. In combination with dexamethasone and doxorubicin, statins have a chemo-sensitizing effect."
"Twenty-eight patients with relapsed myeloma or lymphoma were treated with a dose-escalating regimen of simvastatin for 7...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-07-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.